New treatment for brucellosis

	Tweet

Concepcion Lecaroz, a researcher from the University of Navarra, has developed a new therapy against brucellosis. This zoonosis - a disease or infection of animals which can be transmitted to humans under natural conditions - annually affects 500,000 people worldwide.

This research project forms part of her doctoral thesis, defended at the University’s School of Pharmacy.

This study has permitted the development of a new treatment which significantly reduces infections in mice, as opposed to the traditional treatment with “free” (unencapsulated) antibiotics with short treatment times. 

Despite the fact that brucellosis is highly susceptible to the majority of antibiotics, the indices of relapse in humans ranges from 5 to 15% depending on the antibiotic regimen; in any case, standard treatment requires combined therapy during long periods of time.

The alternative treatment developed by Ms. Leca’roz involves the transportation of the antibiotic gentamicina to infected cells by means of biodegradable particles, which can produce a much higher concentration of antibiotic precisely in the organs which are infected. These biodegradable systems are designed in such a way that they release the antibiotic in a controlled manner, which allows therapeutic levels of antibiotics after a reduced number of dosages.

In this research project, Concepcion Lecaroz has achieved a significant reduction of spleen pathogens in mice, which has led to the possibility of achieving similar results in humans.

In Spain, along with tuberculosis and meningococcal meningitis, brucellosis is one of the most frequent endemic bacterial pathologies. The characteristic symptoms of the disease are fever, chills, weakness, muscular pain, sweating and headaches. If the bacteria invades the bloodstream, it can infect numerous tissues and organs, such as the liver, the spleen, the bones, the genitourinary system, the lungs, the central nervous system, and the heart, to the point of even endangering the life of the patient.

http://www.basqueresearch.com/

RELATED STORIES:
Exposure to Several Common Infections Over Time May Be Associated With Risk of Stroke   More hand-washing won’t curb hospital infections   Japan has first death from human mad cow disease   Less antibiotic use in food animals leads to less drug resistance in people   Contact lenses are home to pathogenic amoebae   Researchers Discover New Ways to Treat Chronic Infections   Man dies of pig-borne disease in Hong Kong   Newborns with low vitamin D levels at increased risk for respiratory infections   Early smoke exposure ups serious infection risk   Combo vaccine less effective than mono version   Vaccine promising against disease-causing HPV   Alligator blood may put the bite on antibiotic-resistant infections

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]